Healio

Healio Minute

Health EN ↓ 164 episodes

The latest health care news you need, when you need it. Only at Healio.

Be sure to visit the podcast's website and support the creator: www.healio.com

Author

Healio

Category

Health

Podcast website

www.healio.com

Latest episode

Nov 9, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Rheumatology/Psoriatic Arthritis Edition: Top Headlines for Week of August 19, 2024 22.08.2024

In this edition, drug discounts through Medicare price negotiations, opioid use has fallen 15% annually since 2014 and more. Read the full coverage here: Enbrel, Stelara to be discounted nearly 70% through Medicare price negotiations Opioid use has fallen 15% annually since 2014 in autoimmune rheumatic disease Inhibitor class PsO treatments exhibit similar efficacy in mitigating PsA risk S100 prot...

Lung Cancer Edition: Top Headlines for Week of August 12, 2024 15.08.2024

In this edition, low education level raises follow-up risk in screening program, screening judgement strongly influenced by clinicians and more. Read the full coverage here: Low education level raises risk for loss to follow-up in lung cancer screening program Lung cancer screening judgement strongly influenced by clinicians Occupational benzene exposure heightens lung cancer likelihood Chemothera...

DME/Retina Edition: Top Headlines for Week of August 5, 2024 08.08.2024

In this edition, sozinibercept combination therapy shows durability, comparable improvements with aflibercept and more. Read the full coverage here: Sozinibercept combination therapy shows durability in patients with DME, neovascular AMD VIDEO: Comparable improvements seen with aflibercept 8 mg vs. 2 mg in DME DPP-IV, SGLT2 and GLP-1 drugs do not increase risk for diabetic macular edema Eluminex d...

Rheumatology/Psoriatic Arthritis Edition: Top Headlines for Week of July 22, 2024 25.07.2024

In this edition, guselkumab brings 'stringent' control through 2 years, SARDs outpatient visits result in opioid prescriptions and more. Read the full coverage here: Guselkumab brings active psoriatic arthritis into 'stringent' control through 2 years Nearly one-quarter of all SARDs outpatient visits in US result in opioid prescription FDA approves biosimilar Pyzchiva for all approved Stelara indi...

Lung Cancer Edition: Top Headlines for Week of July 15, 2024 18.07.2024

In this edition, atezolizumab benefits PD-L1-selected patients with NSCLC, risks persist with e-cigarette use after quitting tobacco smoking and more. Read the full coverage here: Adjuvant atezolizumab benefits PD-L1-selected patients with NSCLC Lung cancer risks persist with e-cigarette use after quitting tobacco smoking COPD, IPF end of life health care use differs from lung cancer Tecentriq com...

DME/Retina Edition: Top Headlines for Week of July 8, 2024 11.07.2024

In this edition, FDA approves Vabysmo prefilled syringe for retinal diseases, 4D Molecular Therapeutics updates on retinal disease candidates and more. Read the full coverage here: FDA approves Vabysmo prefilled syringe for retinal diseases VIDEO: 4D Molecular Therapeutics shares update on retinal disease candidates FDA approves Eylea biosimilar FYB203/Ahzantive VIDEO: Oral therapy improves centra...

Rheumatology/Psoriatic Arthritis Edition: Top Headlines for Week of June 24, 2024 27.06.2024

In this edition, extensive psoriasis and IBD history predict difficult-to-treat psoriatic arthritis, targeted therapies demonstrate low risk for serious infection and more. Read the full coverage here: Extensive psoriasis, IBD history predict difficult-to-treat psoriatic arthritis Targeted psoriatic arthritis therapies demonstrate low risk for serious infection VIDEO: Dermatologists, rheumatologis...

Lung Cancer Edition: Top Headlines for Week of June 17, 2024 20.06.2024

In this edition, screening program identifies airways disease in previously undiagnosed COPD, positive results show benefits of subcutaneous bispecifics and more. Read the full coverage here: Lung cancer screening program identifies airways disease in previously undiagnosed COPD Positive results in lung cancer show benefits of subcutaneous bispecifics Adagrasib delays progression of pretreated KRA...

DME/Retina Edition: Top Headlines for Week of June 3, 2024 06.06.2024

In this edition, AI model helps predict anti-VEGF response in DME, Merck to acquire EyeBio and more. Read the full coverage here: VIDEO: AI model helps predict anti-VEGF response in diabetic macular edema Merck to acquire EyeBio VIDEO: IOP remains stable up to 48 weeks with aflibercept 8 mg for DME Phase 2 study of potential DME oral therapy meets primary endpoints FDA approves aflibercept biosimi...

Rheumatology/Psoriatic Arthritis Edition: Top Headlines for Week of May 20, 2024 23.05.2024

In this edition, difficult-to-treat psoriatic arthritis 'not all about the therapies', Samsung biosimilar comparable to etanercept and more. Read the full coverage here: Difficult-to-treat psoriatic arthritis 'not all about the therapies' Samsung biosimilar comparable to etanercept for psoriatic arthritis outcomes at 1 year Boehringer Ingelheim, Quallent partner to expand Humira biosimilar access...

Lung Cancer Edition: Top Headlines for Week of May 13, 2024 15.05.2024

In this edition, smoking cessation support uptake at lung cancer screenings, glecirasib may deliver 'efficacy and tolerability advantages' and more. Read the full coverage here: Uptake of smoking cessation support high when offered at lung cancer screening Glecirasib may deliver 'efficacy and tolerability advantages' for KRAS-mutant lung cancer 'Substantial geographic disparities' worsening in can...

DME/Retina Edition: Top Headlines for Week of May 6, 2024 09.05.2024

In this edition, FDA accepts new drug application for Eluminex, most mentors in vitreoretinal subspecialty are men and more. Read the full coverage here: FDA accepts investigational new drug application for Eluminex DME treatment Most mentors in vitreoretinal subspecialty are men Carotid artery stenosis linked to retinal changes in patients with diabetic retinopathy AI-assisted technology makes re...

Rheumatology/Psoriatic Arthritis Edition: Top Headlines for Week of April 22, 2024 25.04.2024

In this edition, FDA approves Selarsdi as Stelara biosimilar, deucravacitinib improves 'broad range' of patient-reported outcomes and more. Read the full coverage here: FDA approves Selarsdi as Stelara biosimilar for psoriasis, psoriatic arthritis Deucravacitinib improves 'broad range' of patient-reported psoriatic arthritis outcomes Advanced therapy not enough for nearly 75% of Canadian patients...

Lung Cancer Edition: Top Headlines for Week of April 15, 2024 18.04.2024

In this edition, durvalumab improves survival in limited-stage small cell lung cancer, most adults do not test homes for radon exposure and more. Read the full coverage here: Durvalumab improves survival in limited-stage small cell lung cancer Survey: Most adults do not test homes for radon exposure, unconcerned about risks FDA fast tracks investigational bispecific therapy for aggressive lung can...

DME/Retina Edition: Top Headlines for Week of April 8, 2024 11.04.2024

In this edition, PALADIN study navigates IOP-lowering surgery in DME patients, small-molecule eye drop well-tolerated as treatment for retinal vascular diseases and more. Read the full coverage here: PALADIN study: Navigating IOP-lowering surgery in DME patients for optimal outcomes Small-molecule eye drop safe, well-tolerated as treatment for retinal vascular diseases VIDEO: Reduction of vascular...

Lung Cancer Edition: Top Headlines for Week of March 11, 2024 14.03.2024

In this edition, race identified as risk factor for VTE, FDA approves Rybrevant for treatment of non-small cell lung cancer and more. Read the full coverage here: Race identified as risk factor for VTE after pulmonary resection for lung cancer FDA approves Rybrevant for treatment of non-small cell lung cancer Behavioral health disorders have a 'big impact' on cancer surgery outcomes Optimizing imm...

Lung Cancer Edition: Top Headlines for Week of February 12, 2024 15.02.2024

In this edition, blood test for lung cancer patients who may benefit from further immunotherapy, invasive procedures following lung cancer screenings and more. Read the full coverage here: Blood test identifies those with lung cancer who may benefit from further immunotherapy Invasive procedures rarely follow false-positive lung cancer screenings Study: Positive associations found between smoking...

Lung Cancer Edition: Top Headlines for Week of January 15, 2024 18.01.2024

In this edition, FDA places hold on cell therapy trial after patient death, selpercatinib delivers superior outcomes and more. Read the full coverage here: FDA places hold on trial of cell therapy for lung cancer after patient death Selpercatinib delivers superior outcomes , may 'reduce the burden of NSCLC' First-line immunotherapy benefits patients of all races with NSCLC equally Never-smoker lun...

Dermatology Edition: Top Headlines for Week of December 18, 2023 21.12.2023

In this edition, an advocacy group petitions the FDA for stronger safety warnings for Botox, melanoma regression is associated with improved prognosis and more. Read the full coverage here: Advocacy group petitions FDA for stronger safety warnings for Botox, related drugs Melanoma regression associated with improved prognosis Phase 4 results show Vtama cream efficacious in head, neck plaque psoria...

Dermatology Edition: Top Headlines for Week of December 4, 2023 07.12.2023

In this edition, allergic illnesses in children may be inherited from mothers; addressing needs of Muslim patients in dermatology; YouTube content on topical steroid withdrawal exhibits poor reliability and more. Read the full coverage here: Atopic dermatitis, other allergic illnesses in children may be inherited from mothers Addressing needs of Muslim patients in dermatology YouTube content on to...

Dermatology Edition: Top Headlines for Week of November 13, 2023 16.11.2023

In this edition, dermatologists 'uniquely positioned' to aid human trafficking victims; FDA approves Cosentyx for hidradenitis suppurativa and more. Read the full coverage here: Dermatologists 'uniquely positioned' to recognize, aid human trafficking victims FDA approves Cosentyx as first IL-17A inhibitor for hidradenitis suppurativa FDA approves Stelara biosimilar for treatment of psoriasis, mult...

Prostate Cancer Edition: Top Headlines for Week of November 6, 2023 07.11.2023

In this edition, multicancer detection tests show promise; lifestyle counseling appointments benefit cancer survivors; use of low-value drugs for patients with cancer, and more. Read the full coverage here: Multicancer detection tests show promise, but questions linger about their accessibility Shared medical appointments for lifestyle counseling benefit cancer survivors Industry payments to physi...

Dermatology Edition: Top Headlines for Week of October 30, 2023 02.11.2023

In this edition, FDA approves Bimzelx for plaque psoriasis; roflumilast foam improves quality of life in patients with seborrheic dermatitis and more. Read the full coverage here: FDA approves Bimzelx for treatment of moderate to severe plaque psoriasis Roflumilast foam improves quality of life in patients with seborrheic dermatitis Opzelura effective, well tolerated in children aged at least 2 ye...

Dermatology Edition: Top Headlines for Week of October 16, 2023 19.10.2023

In this edition, FDA issues complete response letter for relabotulinumtoxinA; mucocutaneous manifestations may signal COVID-induced inflammatory disease in children and more. Read the full coverage here: FDA issues complete response letter for relabotulinumtoxinA for frown lines, crow's feet Mucocutaneous manifestations may signal COVID-induced inflammatory disease in children FDA approves Zoryve...

Prostate Cancer Edition: Top Headlines for Week of October 9, 2023 10.10.2023

In this edition, precision navigators reduce racial disparities in genomic testing; cancer diagnoses fell sharply during early days of pandemic; Prostate Cancer Awareness Month updates, and more. Read the full coverage here: Precision navigators reduce racial disparities in genomic testing for prostate cancer Cancer diagnoses fell sharply during early days of pandemic, NCI report shows Prostate Ca...

Listen to the Healio Minute podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.